Results 251 to 260 of about 227,175 (284)
Some of the next articles are maybe not open access.
Anticancer medicines in Pakistan: An analysis of essential medicines lists
Journal of Oncology Pharmacy Practice, 2023Objective The lack of anticancer drugs for curative and supportive purposes is the critical reason for the low survival rate in low-and-middle-income countries. This study aims to analyze whether the National Essential Medicines List (NEML) and Registered Essential Medicines List (REML) are in concordance with the World Health Organization (WHO ...
Sundus Shukar +5 more
openaire +2 more sources
The interpretation of China national essential medicines list 2018
Expert Review of Clinical Pharmacology, 2020Background: In 2018, China implemented the latest National Essential Medicines List (NEML) by enhancing the NEML 2012. The goal of our studies is to analyze the changes in the two lists and compared them with the 20th EML issued by WHO in 2017. And then provide suggestions for emerging problems.Method: The overall composition of the categories ...
Wei, Zuo +6 more
openaire +2 more sources
The Essential Medicines List for a Global Patient Population
Clinical Pharmacology & Therapeutics, 2007Thirty years after its inception, the role, audience, and contents of the global Essential Medicines List (EML) are reviewed. Challenges for decision makers in applying the principles of medicine selection based on efficacy, safety, burden of disease, and cost effectiveness are discussed and illustrated with recent decisions of the Expert Committee ...
J, Robertson, S R, Hill
openaire +2 more sources
Lucentis excluded from WHO list of essential medicines
BMJ, 2015The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug ...
openaire +1 more source
Essential medicines lists are for high income countries too
BMJ, 2023Petra, Brhlikova +3 more
openaire +2 more sources
The WHO fungal priority pathogens list as a game-changer
Nature Reviews Microbiology, 2023Matthew C Fisher, David W Denning
exaly
Enhancing global access to cancer medicines
Ca-A Cancer Journal for Clinicians, 2020Javier Cortes +2 more
exaly
The microbiome-shaping roles of bacteriocins
Nature Reviews Microbiology, 2021Simon Heilbronner +2 more
exaly
Developing an essential medicines list for livestock
Veterinary Record, 2021openaire +1 more source